2019 | 2018 | 2017 |2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003
2019
Thomas J. Jackson, Gordan M. Vujanić, Kathy Pritchard-Jones
Comment on: "Indications and results of diagnostic biopsy in pediatric renal tumors: A retrospective analysis of 317 patients with critical review of SIOP guidelines"
Pediatr Blood Cancer. 2019 Apr 02;:e27746 doi: 10.1002/pbc.27746. [Epub ahead of print] ->Abstract PubMed
Kathy Pritchard-Jones, Perotti D
WARNING: G-401 and SK-NEP-1 cell lines are not Wilms tumor cell lines.
Pediatr Blood Cancer. 2019; e27741 doi: 10.1002/pbc.27741. [Epub ahead of print] ->Abstract PubMed
Shazia Mahamdallie, Shawn Yost, Emma Poyastro-Pearson, Esty Holt, Anna Zachariou, Sheila Seal, Anna Elliott, Matthew Clarke, Margaret Warren-Perry, Sandra Hanks, John Anderson, Simon Bomken, Trevor Cole, Roula Farah, Rhoikos Furtwaengler, Adam Glaser, Richard Grundy, James Hayden, Steve Lowis, Frédéric Millot, James Nicholson, Milind Ronghe, Jane Skeen, Denise Williams, Daniel Yeomanson, Elise Ruark, Nazneen Rahman
Identification of new Wilms tumour predisposition genes: an exome sequencing study
Lancet Child Adolesc Health, 2019 doi: 10.1016/S2352-4642(19)30018-5. [Epub ahead of print] ->Abstract PubMed
Jackson TJ, Williams RD, Brok J, Chowdhury T, Ronghe M, Powis M, Pritchard-jones K, Vujanic GM on behalf of the Children's Cancer and Leukaemia Group (CCLG) Renal Tumours Group
The diagnostic accuracy and clinical utility of pediatric renal tumor biopsy: Report of the UK experience in the SIOP UK WT 2001 trial
Pediatr Blodd Cancer, 2019, doi: 10.1002/pbc.27627. [Epub ahead of print] ->Abstract PubMed
de la Monneraye Y, Michon J, Pacquement H, Aerts I, Orbach D, Doz F, Bourdeaut F, Sarnacki S, Philippe-Chomette P, Audry G, Coulomb A, Fréneaux P, Klijanienko J, Berrebi D, Zucker JM, Schleiermacher G, Brisse HJ
Indications and results of diagnostic biopsy in pediatric renal tumors: A retrospective analysis of 317 patients with critical review of SIOP guidelines
Pediatr Blodd Cancer, 2019, doi: 10.1002/pbc.27641. [Epub ahead of print] ->Abstract PubMed
Illja J. Diets, Juliane Hoyer, Arif B Ekici, Bernt Popp, Nicoline Hoogerbrugge, Simon van Reijmersdal, Rajith Bhaskaran, Michel Hadjihannas, Georgia Vasileiou, Christian T. Thiel, Didem Seven, Steffen Uebe, Denisa Ilencikova, Esmé Waanders, Annelies MC Mavinkurve, Nel Roeleveld, Ronald de Krijger, Jenny Wegert, Norbert Graf, Christian Vokuhl, Abbas Agaimy, Manfred Gessler, André Reis, Roland P. Kuiper, Marjolijn C. Jongmans, Markus Metzler
TRIM28 haploinsufficiency predisposes to Wilms tumor
Int J Cancer, 2019, doi: 10.1002/ijc.32167. [Epub ahead of print] ->Abstract PubMed
Vujanic GM, Lena MS, Sebire NJ
Botryoid Wilms tumor: a non-existent "entity" causing diagnostic and staging difficulties
Virchows Archiv 474:227-234, 2019, doi: 10.1002/pbc.27549 ->Abstract PubMed
Vujanic GM, D'Hooghe E, Popov SD, Sebire NJ, Kelsey A
The effect of preoperative chemotherapy on histological subtyping and staging ofWilms tumors: The United Kingdom Children's Cancer Study Group (UKCCSG)Wilms tumor trial 3 (UKW3) experience
Pediatr Blood Cancer 66:e27549, 2019, doi: 10.1002/pbc.27549 ->Abstract PubMed
Kehl T, Schneider L, Kattler K, Stöckel D, Wegert J, Gerstner N, Ludwig N, Distler U, Tenzer S, Gessler M, Walter J, Keller A, Graf N, Meese E, Lenhof HP
The role of TCF3 as potential master regulator in blastemal Wilms tumors
Int J Cancer 144:1432-1443, 2019. doi: 10.1002/ijc.31834->Abstract PubMed
Irtan S, Messahel B, Moroz V, Taylor RF, Grundy R, Kelsey A, Vujanic G, Pritchard-Jones K on behalf of the Renal Tumours Committee of the Children's Cancer and Leukaemia Group (CCLG)
Outcomes of non-anaplastic stage III and 'inoperable' Wilms tumour treated in the UKW3 trial
Radiotherapy and Oncology 131:1-7, 2019, doi: 10.1016/j.radonc.2018.10.026 -> Abstract Pubmed
Oostveen RM, Pritchard-Jones K
Pharmacotherapeutic Management of Wilms Tumor: An Update
Pediatric Drugs, 2019, doi: 10.1007/s40272-018-0323-z -> Abstract Pubmed
